Cargando…
E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model
The response to ischemia in peripheral artery disease (PAD) depends on compensatory neovascularization and coordination of tissue regeneration. Identifying novel mechanisms regulating these processes is critical to the development of nonsurgical treatments for PAD. E-selectin is an adhesion molecule...
Autores principales: | Ribieras, Antoine J., Ortiz, Yulexi Y., Li, Yan, Le, Nga T., Huerta, Carlos T., Voza, Francesca A., Shao, Hongwei, Vazquez-Padron, Roberto I., Liu, Zhao-Jun, Velazquez, Omaida C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219778/ https://www.ncbi.nlm.nih.gov/pubmed/37251271 http://dx.doi.org/10.1155/2023/6679390 |
Ejemplares similares
-
E-Selectin/AAV2/2 Gene Therapy Alters Angiogenesis and Inflammatory Gene Profiles in Mouse Gangrene Model
por: Ribieras, Antoine J., et al.
Publicado: (2022) -
Novel Gene-Modified Mesenchymal Stem Cell Therapy Reverses Impaired Wound Healing in Ischemic Limbs
por: Huerta, Carlos Theodore, et al.
Publicado: (2023) -
Therapeutic angiogenesis in Buerger’s disease: reviewing the
treatment landscape
por: Ribieras, Antoine J., et al.
Publicado: (2022) -
Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies
por: Huerta, Carlos Theodore, et al.
Publicado: (2023) -
E-Selectin-Overexpressing Mesenchymal Stem Cell Therapy Confers Improved Reperfusion, Repair, and Regeneration in a Murine Critical Limb Ischemia Model
por: Quiroz, Hallie J., et al.
Publicado: (2022)